{"title":"晚期卵巢癌患者营养不良患病率及其对手术和肿瘤预后的影响:一项综合分析。","authors":"Kittithach Pischart, Khemanat Khemworapong, Pattama Chaopotong, Vuthinun Achariyapota","doi":"10.1155/ogi/2918759","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objective:</b> Malnutrition is a major concern in patients with advanced ovarian cancer, and this condition may be associated with poor treatment outcomes. This study aims to estimate the prevalence of malnutrition in advanced ovarian cancer patients and investigate its impact on both surgical and oncological outcomes. <b>Materials and Methods:</b> This retrospective study included 290 advanced-stage ovarian cancer patients (FIGO stage III-IV) who were not diagnosed with malnutrition. The median follow-up time was 36 months. Malnutrition was defined using the Geriatric Nutritional Risk Index (GNRI). Retrospective data on patient characteristics, treatment complications, and outcomes were recorded. Statistical analyses were performed using IBM SPSS Statistics for Windows (Version 26.0; IBM Corp., Armonk, NY, USA). <b>Results:</b> This study found that 137 of 290 patients (47.2%) had malnutrition. Anemia and chronic kidney disease (CKD) were frequently observed alongside malnutrition. Malnutrition impacts both surgical and oncological outcomes, including the rate of optimal debulking surgeries (35.8% in the malnourished group and 62.7% in the well-nourished group, <i>p</i> < 0.005) and the median length of hospital stay (10 days in the malnourished group and 7 days in the well-nourished group, <i>p</i> < 0.005). Additionally, well-nourished patients had a significant higher overall survival rate (43 months) compared to malnourished patients (30 months). <b>Conclusion:</b> Malnutrition is common among patients with advanced ovarian cancer and is associated with a lower rate of optimal surgery, longer hospital stays, and reduced overall survival rates.</p>","PeriodicalId":19439,"journal":{"name":"Obstetrics and Gynecology International","volume":"2025 ","pages":"2918759"},"PeriodicalIF":1.6000,"publicationDate":"2025-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12085243/pdf/","citationCount":"0","resultStr":"{\"title\":\"Malnutrition Prevalence and Its Implications on Surgical and Oncological Outcomes in Advanced Ovarian Cancer Patients: A Comprehensive Analysis.\",\"authors\":\"Kittithach Pischart, Khemanat Khemworapong, Pattama Chaopotong, Vuthinun Achariyapota\",\"doi\":\"10.1155/ogi/2918759\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Objective:</b> Malnutrition is a major concern in patients with advanced ovarian cancer, and this condition may be associated with poor treatment outcomes. This study aims to estimate the prevalence of malnutrition in advanced ovarian cancer patients and investigate its impact on both surgical and oncological outcomes. <b>Materials and Methods:</b> This retrospective study included 290 advanced-stage ovarian cancer patients (FIGO stage III-IV) who were not diagnosed with malnutrition. The median follow-up time was 36 months. Malnutrition was defined using the Geriatric Nutritional Risk Index (GNRI). Retrospective data on patient characteristics, treatment complications, and outcomes were recorded. Statistical analyses were performed using IBM SPSS Statistics for Windows (Version 26.0; IBM Corp., Armonk, NY, USA). <b>Results:</b> This study found that 137 of 290 patients (47.2%) had malnutrition. Anemia and chronic kidney disease (CKD) were frequently observed alongside malnutrition. Malnutrition impacts both surgical and oncological outcomes, including the rate of optimal debulking surgeries (35.8% in the malnourished group and 62.7% in the well-nourished group, <i>p</i> < 0.005) and the median length of hospital stay (10 days in the malnourished group and 7 days in the well-nourished group, <i>p</i> < 0.005). Additionally, well-nourished patients had a significant higher overall survival rate (43 months) compared to malnourished patients (30 months). <b>Conclusion:</b> Malnutrition is common among patients with advanced ovarian cancer and is associated with a lower rate of optimal surgery, longer hospital stays, and reduced overall survival rates.</p>\",\"PeriodicalId\":19439,\"journal\":{\"name\":\"Obstetrics and Gynecology International\",\"volume\":\"2025 \",\"pages\":\"2918759\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2025-05-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12085243/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Obstetrics and Gynecology International\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1155/ogi/2918759\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obstetrics and Gynecology International","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/ogi/2918759","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
目的:营养不良是晚期卵巢癌患者的一个主要问题,这种情况可能与不良的治疗结果有关。本研究旨在估计晚期卵巢癌患者营养不良的患病率,并探讨其对手术和肿瘤预后的影响。材料与方法:本回顾性研究纳入290例未诊断为营养不良的晚期卵巢癌患者(FIGO III-IV期)。中位随访时间为36个月。营养不良的定义采用老年营养风险指数(GNRI)。记录患者特征、治疗并发症和结果的回顾性数据。采用IBM SPSS Statistics for Windows (Version 26.0;IBM公司,美国纽约州阿蒙克市)。结果:290例患者中有137例(47.2%)存在营养不良。贫血和慢性肾脏疾病(CKD)经常与营养不良一起被观察到。营养不良影响手术和肿瘤预后,包括最佳减重手术率(营养不良组为35.8%,营养良好组为62.7%)。结论:营养不良在晚期卵巢癌患者中很常见,与较低的最佳手术率、较长的住院时间和较低的总生存率相关。
Malnutrition Prevalence and Its Implications on Surgical and Oncological Outcomes in Advanced Ovarian Cancer Patients: A Comprehensive Analysis.
Objective: Malnutrition is a major concern in patients with advanced ovarian cancer, and this condition may be associated with poor treatment outcomes. This study aims to estimate the prevalence of malnutrition in advanced ovarian cancer patients and investigate its impact on both surgical and oncological outcomes. Materials and Methods: This retrospective study included 290 advanced-stage ovarian cancer patients (FIGO stage III-IV) who were not diagnosed with malnutrition. The median follow-up time was 36 months. Malnutrition was defined using the Geriatric Nutritional Risk Index (GNRI). Retrospective data on patient characteristics, treatment complications, and outcomes were recorded. Statistical analyses were performed using IBM SPSS Statistics for Windows (Version 26.0; IBM Corp., Armonk, NY, USA). Results: This study found that 137 of 290 patients (47.2%) had malnutrition. Anemia and chronic kidney disease (CKD) were frequently observed alongside malnutrition. Malnutrition impacts both surgical and oncological outcomes, including the rate of optimal debulking surgeries (35.8% in the malnourished group and 62.7% in the well-nourished group, p < 0.005) and the median length of hospital stay (10 days in the malnourished group and 7 days in the well-nourished group, p < 0.005). Additionally, well-nourished patients had a significant higher overall survival rate (43 months) compared to malnourished patients (30 months). Conclusion: Malnutrition is common among patients with advanced ovarian cancer and is associated with a lower rate of optimal surgery, longer hospital stays, and reduced overall survival rates.
期刊介绍:
Obstetrics and Gynecology International is a peer-reviewed, Open Access journal that aims to provide a forum for scientists and clinical professionals working in obstetrics and gynecology. The journal publishes original research articles, review articles, and clinical studies related to obstetrics, maternal-fetal medicine, general gynecology, gynecologic oncology, uro-gynecology, reproductive medicine and infertility, reproductive endocrinology, and sexual medicine.